TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $28,819,000 | +35.2% | 329,890 | 0.0% | 0.42% | +22.0% |
Q2 2020 | $21,308,000 | +38.0% | 329,890 | -5.7% | 0.34% | -14.2% |
Q1 2020 | $15,441,000 | -43.3% | 349,890 | -20.0% | 0.40% | -25.7% |
Q4 2019 | $27,245,000 | +21.3% | 437,390 | -26.8% | 0.54% | -10.6% |
Q3 2019 | $22,454,000 | +29.8% | 597,190 | +40.5% | 0.60% | +52.4% |
Q2 2019 | $17,296,000 | – | 424,968 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |